With respect to macrophage secretory factors, CIDP patients were treated with IVIg and evaluated for serum levels of macrophage colony-stimulating factor (M-CSF) and monocyte chemoattractant protein-1 (MCP-1) [54]. This evidence concerns the gene CCL2 and chronic inflammatory demyelinating polyradiculoneuropathy.